Inventor

BUCHARDT JENS

DK9 patents

⚠️ This page may combine multiple inventors who share the name “BUCHARDT JENS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BEHRENS CARSTEN

2 patents

US9018166B2Apr 28, 2015

Conjugated FVIII variants

BEHRENS CARSTEN2 citations58

US9695226B2Jul 4, 2017

Growth hormones with prolonged in-vivo efficacy

BEHRENS CARSTEN1 citations50

BUCHARDT JENS

2 patents

US8586532B2Nov 19, 2013

Method for selectively modifying a protein via transglutaminase catalyzed reaction

BUCHARDT JENS2 citations48

US9234192B2Jan 12, 2016

Conjugated proteins

BUCHARDT JENS0 citations36

NOVO NORDISK AS

2 patents

US9713644B2Jul 25, 2017

Antagonistic DR3 ligands

NOVO NORDISK AS0 citations47

US8765130B2Jul 1, 2014

Antagonistic DR3 ligands

NOVO NORDISK AS0 citations47

JOHANSEN NILS LANGELAND

1 patent

US8841249B2Sep 23, 2014

Growth hormones with prolonged in-vivo efficacy

JOHANSEN NILS LANGELAND9 citations80

ANDERSEN METTE DAHL

1 patent

US9737612B2Aug 22, 2017

Antagonistic DR3 ligands

ANDERSEN METTE DAHL3 citations65

CARLSBERG AS

1 patent

US7064179B1Jun 20, 2006

Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions

CARLSBERG AS2 citations58